Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
(责任编辑:컴퓨터)
下一篇:Enjoying Halloween in Itaewon sparks debate online
- ·Discussions on need for dialogue on N. Korea denuclearization diminish in US: ambassador
- ·Korea extends fuel tax cut scheme until year's end
- ·Blackpink's Jennie makes solo debut on Official UK Singles Chart
- ·SK Ecoplant recycles over 6,000 tons of batteries
- ·HD Korea Shipbuilding to build world's first ammonia
- ·BTS Jungkook's star
- ·'Scent of Ink' to be performed at Kennedy Center in Washington
- ·김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
- ·Import prices up for 3rd month in September on higher oil prices
- ·[Top Envoy] Russian satellite help not likely priority for North Korea: Chun
- ·[Our Museums] Discover wisdom of hanok at Eunpyeong History Hanok Museum
- ·Foreign workers' deaths get weak sanctions
- ·Seoul shares open higher on US gains
- ·Hamas weapons, tactics resemble those of NK: JCS
- ·[Today’s K
- ·USS Carl Vinson deploys for Indo
- ·[Top Envoy] Russian satellite help not likely priority for North Korea: Chun
- ·[Contribution] Why hope matters in climate crisis
- ·Supporters of Israel hold rally in Seoul, urge Hamas to stop atrocities
- ·Hyundai Rotem to showcase new ground weapons systems at Seoul expo
- ·S. Korean diplomat discusses NK human rights with US envoy
- ·Over 1,300 rescue workers still traumatized by Itaewon Halloween tragedy
- ·北, 러시아 외무장관 방북 발표…내달 18~19일 방문
- ·Yoon, doctors set to clash over medical school quota
- ·New government initiative offers W3b reward to combat digital piracy
- ·오세훈, ‘TBS 폐지’ 묻자 “그런 일 생겨서는 안 돼”
- ·Beef prices have soared 100